Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | D(4) dopamine receptor |
---|
Ligand | BDBM50058225 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_382037 (CHEMBL863649) |
---|
EC50 | 8.3±n/a nM |
---|
Citation | Kolasa, T; Matulenko, MA; Hakeem, AA; Patel, MV; Mortell, K; Bhatia, P; Henry, R; Nakane, M; Hsieh, GC; Terranova, MA; Uchic, ME; Miller, LN; Chang, R; Donnelly-Roberts, DL; Namovic, MT; Hollingsworth, PR; Martino, B; El Kouhen, O; Marsh, KC; Wetter, JM; Moreland, RB; Brioni, JD; Stewart, AO 1-aryl-3-(4-pyridine-2-ylpiperazin-1-yl)propan-1-one oximes as potent dopamine D4 receptor agonists for the treatment of erectile dysfunction. J Med Chem49:5093-109 (2006) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
D(4) dopamine receptor |
---|
Name: | D(4) dopamine receptor |
Synonyms: | D(2C) dopamine receptor | DOPAMINE D4 | DOPAMINE D4.2 | DOPAMINE D4.4 | DRD4 | DRD4_HUMAN | Dopamine D4 receptor |
Type: | Enzyme |
Mol. Mass.: | 48373.19 |
Organism: | Homo sapiens (Human) |
Description: | P21917 |
Residue: | 419 |
Sequence: | MGNRSTADADGLLAGRGPAAGASAGASAGLAGQGAAALVGGVLLIGAVLAGNSLVCVSVA
TERALQTPTNSFIVSLAAADLLLALLVLPLFVYSEVQGGAWLLSPRLCDALMAMDVMLCT
ASIFNLCAISVDRFVAVAVPLRYNRQGGSRRQLLLIGATWLLSAAVAAPVLCGLNDVRGR
DPAVCRLEDRDYVVYSSVCSFFLPCPLMLLLYWATFRGLQRWEVARRAKLHGRAPRRPSG
PGPPSPTPPAPRLPQDPCGPDCAPPAPGLPRGPCGPDCAPAAPSLPQDPCGPDCAPPAPG
LPPDPCGSNCAPPDAVRAAALPPQTPPQTRRRRRAKITGRERKAMRVLPVVVGAFLLCWT
PFFVVHITQALCPACSVPPRLVSAVTWLGYVNSALNPVIYTVFNAEFRNVFRKALRACC
|
|
|
BDBM50058225 |
---|
n/a |
---|
Name | BDBM50058225 |
Synonyms: | CHEMBL45244 | N-((4-(2-cyanophenyl)piperazin-1-yl)methyl)-3-methylbenzamide | N-[4-(2-Cyano-phenyl)-piperazin-1-ylmethyl]-3-methyl-benzamide | PD-168077 |
Type | Small organic molecule |
Emp. Form. | C20H22N4O |
Mol. Mass. | 334.4149 |
SMILES | Cc1cccc(c1)C(=O)NCN1CCN(CC1)c1ccccc1C#N |
Structure |
|